Artivion, Inc. (AORT)

37.72 +0.98 (+2.67%) USD  |  NYSE  |  Apr 17, 16:00
37.72 0.00 (0.00%) Pre-Market: 06:57
More

Artivion SG&A Expense (Quarterly) : 56.84M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for AORT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
NeuroOne Medical Technologies Corp. 1.886M
Edwards Lifesciences Corp. 602.90M
Zimmer Biomet Holdings, Inc. 872.30M
PetVivo Holdings, Inc. 2.013M
Nutriband, Inc. 3.492M